BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 253 filers reported holding BIONTECH SE in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,486,521 | +114.3% | 13,683 | +112.9% | 0.00% | – |
| Q2 2023 | $693,558 | -27.9% | 6,426 | -16.8% | 0.00% | -100.0% |
| Q1 2023 | $962,054 | +9.6% | 7,723 | +32.2% | 0.00% | 0.0% |
| Q4 2022 | $877,585 | -5.3% | 5,842 | -15.0% | 0.00% | 0.0% |
| Q3 2022 | $927,000 | +7.4% | 6,875 | +18.8% | 0.00% | 0.0% |
| Q2 2022 | $863,000 | -35.7% | 5,787 | -26.5% | 0.00% | 0.0% |
| Q1 2022 | $1,343,000 | -51.4% | 7,874 | -26.5% | 0.00% | -50.0% |
| Q4 2021 | $2,762,000 | -26.0% | 10,713 | -21.6% | 0.00% | -50.0% |
| Q3 2021 | $3,731,000 | +241.7% | 13,667 | +180.2% | 0.00% | +300.0% |
| Q2 2021 | $1,092,000 | +183.6% | 4,878 | +38.2% | 0.00% | – |
| Q1 2021 | $385,000 | +55.9% | 3,530 | +16.4% | 0.00% | – |
| Q4 2020 | $247,000 | +8.8% | 3,032 | -7.3% | 0.00% | – |
| Q3 2020 | $227,000 | – | 3,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |